Yoga for Breast Cancer

This study is currently recruiting participants.
Verified November 2013 by Abramson Cancer Center of the University of Pennsylvania
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01985945
First received: November 11, 2013
Last updated: NA
Last verified: November 2013
History: No changes posted
  Purpose

The purpose of this study is to examine the use of Eischens yoga for 8 weeks in one cohort of 20 women with stage I and II breast cancer receiving radiation therapy treatment, while a second cohort of the same type of and number of patients who, instead of yoga will receive standard supportive therapy, Questionnaire measuring cancer-related quality of life (FACT-G instrument) and fatigue (Brief Fatique Inventory) will be given to patients at several points.


Condition Intervention
Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy
Other: Yoga

Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Primary Purpose: Supportive Care
Official Title: A Randomized Study of the Effect of Yoga in Patients With Breast Cancer Receiving Radiation Therapy

Resource links provided by NLM:


Further study details as provided by Abramson Cancer Center of the University of Pennsylvania:

Primary Outcome Measures:
  • Number of Adverse Events [ Time Frame: One Year ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 20
Study Start Date: March 2013
Estimated Study Completion Date: March 2014
Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Yoga Other: Yoga
No Intervention: Without Yoga

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Stage I and II breast cancer patients undergoing active radiation therapy
  • Above the age of 18
  • Must sign informed consent form
  • Must speak English
  • Only women are eligible

Exclusion Criteria:

  • Patients with medical restrictions that may interfere with yoga participation per their physicians' decision
  • Those who have smoked in the last 6 months because smoking can interfere with the breathing and relaxation techniques of yoga.
  • Those who have regularly taken yoga in the last 6 months, because they would not come to the intervention with the same baseline as other participants.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01985945

Contacts
Contact: Lilie Lin, MD 855-216-0098 PennCancerTrials@emergingmed.com

Locations
United States, Pennsylvania
Abramson Cancer Center of the University of Pennsylvania Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Lilie Lin, MD    855-216-0098    PennCancerTrials@emergingmed.com   
Principal Investigator: Lilie Lin, MD         
Sponsors and Collaborators
Abramson Cancer Center of the University of Pennsylvania
Investigators
Principal Investigator: Lilie Lin, MD Abramson Cancer Center of the University of Pennsylvania
  More Information

No publications provided

Responsible Party: Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier: NCT01985945     History of Changes
Other Study ID Numbers: UPCC 08113
Study First Received: November 11, 2013
Last Updated: November 11, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on April 15, 2014